Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancerWeihao Li, Junzhong Lin, Chi Zhou et al.|Autophagy|2023Cited by 387
Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosisJunzhong Lin, Zhizhong Pan, Yujie Zhao et al.|Journal of Cancer Research and Clinical Oncology|2017Cited by 56